Scientific News Boston Scientific Lifts Sales Outlook, Notes Key Approval Of Afib Device With Minnesota Ties
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific Lifts Sales Outlook, Notes Key Approval Of Afib Device With Minnesota Ties is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Boston Scientific Up 7% in a Month: How Should You Play the Stock?
Shares of Boston Scientific BSX have climbed 7% over the past 30 days, extending their positive year-to-date momentum. The stock’s performance has outpaced its industry’s 0.9% gains, the broader ... Read More
Boston Scientific to stop heart device sales amid regulatory challenges
May 28 (Reuters) - Boston Scientific (BSX.N), opens new tab said on Wednesday it has discontinued sales of its heart device in the European Union and will not seek approval in the U.S. and other ... Read More
UBS Boosts Boston Scientific (BSX) Price Target After Strong Q3 Earnings
Boston Scientific Corporation (NYSE:BSX) ranks among the best long-term stocks to buy according to D. E. Shaw. On October 23, UBS maintained its Buy rating on Boston Scientific Corporation (NYSE:BSX) ... Read More
Boston Scientific lifts annual profit forecast, sees smaller tariff impact
July 23 (Reuters) - Boston Scientific (BSX.N), opens new tab raised its annual profit forecast on Wednesday, banking on strong demand for its heart devices, and trimmed its expectation for ... Read More
Boston Scientific Ending Acurate Sales, Approval Efforts -- Update
Boston Scientific is throwing in the towel on its Acurate transcatheter aortic valve replacement, or TAVR, platform, citing rising costs of efforts to win regulatory approvals. Boston Scientific on ... Read More
Boston Scientific Secures Watchman Label Expansion
Boston Scientific has secured label expansion from FDA for its Watchman FLX and Watchman FLX Pro. The Marlborough, MA-based company had already expected the label expansion, which now includes ... Read More
Boston Scientific Ending Acurate Sales, Approval Efforts — Update
Boston Scientific is throwing in the towel on its Acurate transcatheter aortic valve replacement, or TAVR, platform, citing rising costs of efforts to win regulatory approvals. Boston Scientific on ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus